ALIO Medicasp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2012-04-26
Share capital
5 000,00 PLN
Registered address
ul. Górzysta 15, 85-167 Bydgoszcz, Poland
Electronic delivery address
AE:PL-41695-84186-WGERW-25
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 50.56kMedianUSD 436.68kAverageUSD 6.29m
Net profit
This companyUSD 2.25kMedianUSD 6.74kAverageUSD 451.09k
Operating costs
This companyUSD 48.32kMedianUSD 453.01kAverageUSD 5.58m
Assets
This companyUSD 8.71kMedianUSD 379.12kAverageUSD 5.64m
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-07-17. Active
10 1050 1139 1000 0090 8019 1456
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 14, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | PREZYDENT MIASTA BYDGOSZCZ |
Tenders
No recorded participation in tenders.
Authorized Representatives
Adam Łukasz Uhlenberg — President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently (autonomous representation).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Łukasz Uhlenberg (50) | 48 | $1,296.60 | 96% |
Others | 2 | $54.02 | 4% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Adam Łukasz Uhlenberg (50) | Shareholder of a limited liability company, 4800.0 PLN |
Subsidiaries
| Name | Stake | |
|---|---|---|
Alio Medica Sp.J.sp. j. | — |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Erbafarm Naturalesp. z o.o. | $574,147.77 | erbafarm.pl | ||
| Epicgreensp. z o.o. | $181,308.02 | epicgreen.pl | ||
| Natura Organicasp. z o.o. | $128,773.68 | naturaorganica.pl | ||
| Propharmsp. z o.o. | $25,859.81 | propharm.pl | ||
| Vianatsp. z o.o. | $20,652.52 | vianat.eu | ||
| Vasco Techsp. z o.o. | $18,452.60 | vascotech.pl | ||
| Symbio PolskaS.A. | $9,938.92 | symbio.pl | ||
| BEE & Sonssp. z o.o. | $8,782.50 | beeandsons.com | ||
| Noblepharma Bissp. z o.o. | $0.19 | noblepharma.pl | ||
| Taorasp. z o.o. | $0.08 | taora.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-03-05 | Address change (Kopernika 28a, 86-032, Niemcz → Ul. Górzysta 15, 85-167, Bydgoszcz) | |
| 2012-04-26 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on April 26, 2012.
The headquarters is located at: ul. Górzysta 15, 85-167 Bydgoszcz.
The management board consists of: Adam Łukasz Uhlenberg (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $50,563 in 2024, which is an increase of 50.5% compared to 2023.
Yes, in 2024 the company achieved a net profit of $2,247.
The largest operating cost category falls under other operating costs. This category amounted to $48,316 in 2024, representing 100% of all operating expenses.
Last updated: 2026-04-22